Showing results (701-710 of 995) with videos related to
Sort By:
Pageof 100
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE studyF Nuzzo, C Gallo, S Lastoria, et al.Leukemia|April 27, 2016
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonistsV De Stefano, M Ruggeri, F Cervantes, et al.Nature Communications|October 4, 2023
Visualizing moiré ferroelectricity via plasmons and nano-photocurrent in graphene/twisted-WSe2 structuresShuai Zhang, Yang Liu, Zhiyuan Sun, et al.Blood Cancer Journal|November 5, 2016
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patientsV De Stefano, A M Vannucchi, M Ruggeri, et al.Cardiovascular Diabetology|August 5, 2024
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trialRoberto Minutolo, Vittorio Simeon, Luca De Nicola, et al.Leukemia & Lymphoma|July 29, 2016
Hodgkin's Disease in 50 Intravenous Drug Users with HIV-InfectionS Monfardini, U Tirelli, E Vaccher, et al.Pageof 100